Total Payments
$4,575
2024 Payments
$746.83
Companies
39
Transactions
265
Medicare Patients
7,870
Medicare Billing
$446,561
Payment Breakdown by Category
Food & Beverage$4,520 (98.8%)
Education$55.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,520 | 264 | 98.8% |
| Education | $55.00 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $951.89 | 59 | $0 (2024) |
| ABBVIE INC. | $495.87 | 33 | $0 (2024) |
| Boston Scientific Corporation | $472.96 | 19 | $0 (2020) |
| Amgen Inc. | $381.46 | 25 | $0 (2024) |
| PFIZER INC. | $312.65 | 26 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $255.50 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $199.01 | 13 | $0 (2024) |
| Medtronic, Inc. | $154.87 | 3 | $0 (2024) |
| ROCHESTER MEDICAL CORPORATION | $148.72 | 5 | $0 (2019) |
| Myovant Sciences Inc. | $93.18 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $746.83 | 44 | Sumitomo Pharma America, Inc. ($207.95) |
| 2023 | $417.95 | 17 | Medtronic, Inc. ($130.63) |
| 2022 | $310.51 | 18 | Astellas Pharma US Inc ($51.84) |
| 2021 | $445.41 | 26 | Astellas Pharma US Inc ($191.33) |
| 2020 | $456.57 | 27 | Astellas Pharma US Inc ($110.09) |
| 2019 | $787.68 | 41 | Boston Scientific Corporation ($248.65) |
| 2018 | $744.15 | 42 | Astellas Pharma US Inc ($252.05) |
| 2017 | $665.97 | 50 | Amgen Inc. ($152.21) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: Oncology | ||||||
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: UROLOGY | ||||||
| 09/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 08/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Oncology | ||||||
| 07/31/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $38.28 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: UROLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Oncology | ||||||
| 06/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: UROLOGY | ||||||
| 06/12/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Immunotherapy | ||||||
| 05/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA, AKEEGA | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 771 | 829 | $82,590 | $29,392 |
| 2022 | 14 | 2,007 | 2,694 | $273,354 | $100,019 |
| 2021 | 23 | 2,460 | 3,310 | $448,835 | $158,404 |
| 2020 | 22 | 2,632 | 3,610 | $481,656 | $158,746 |
Total Patients
7,870
Total Services
10,443
Medicare Billing
$446,561
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 156 | $24,432 | $10,578 | 43.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 41 | 41 | $20,664 | $6,415 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $14,614 | $5,642 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 50 | $5,056 | $2,141 | 42.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 83 | 84 | $5,628 | $1,514 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 45 | $2,738 | $1,005 | 36.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 90 | 92 | $736.00 | $721.28 | 98.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 145 | 156 | $1,872 | $614.64 | 32.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 59 | 62 | $4,618 | $415.90 | 9.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 16 | $480.00 | $184.36 | 38.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 63 | 73 | $1,752 | $160.60 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 350 | 446 | $66,008 | $35,106 | 53.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 17 | 139 | $90,350 | $19,034 | 21.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 65 | 85 | $30,600 | $14,417 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 148 | $14,504 | $7,877 | 54.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 271 | 352 | $23,584 | $6,395 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $10,350 | $4,491 | 43.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 139 | 148 | $8,880 | $4,399 | 49.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 516 | 728 | $8,736 | $2,892 | 33.1% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 17 | 17 | $4,760 | $1,689 | 35.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 283 | 374 | $2,992 | $1,108 | 37.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 49 | 70 | $2,100 | $1,023 | 48.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 87 | 99 | $4,950 | $629.30 | 12.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 18 | 25 | $1,800 | $550.64 | 30.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 17 | 17 | $3,740 | $407.67 | 10.9% |
About Dr. Michael Severance, MD
Dr. Michael Severance, MD is a Urology healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790708907.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Severance, MD has received a total of $4,575 in payments from pharmaceutical and medical device companies, with $746.83 received in 2024. These payments were reported across 265 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,520).
As a Medicare-enrolled provider, Severance has provided services to 7,870 Medicare beneficiaries, totaling 10,443 services with total Medicare billing of $446,561. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Jefferson City, MO
- Active Since 07/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1790708907
Products in Payments
- XTANDI (Drug) $602.50
- Prolia (Biological) $360.77
- MYRBETRIQ (Drug) $313.09
- GEMTESA (Drug) $261.40
- LUPRON DEPOT (Drug) $186.94
- ERLEADA (Drug) $177.03
- INTERSTIM (Device) $168.55
- Myrbetriq (Drug) $143.92
- LITHOVUE (Device) $140.54
- GENERAL THERAPIES (Device) $139.80
- MAGIC3 (Device) $137.93
- Lupron Depot (Drug) $117.83
- ORGOVYX (Drug) $112.91
- (815) Thiola (Drug) $83.77
- Nubeqa (Drug) $80.93
- GENERAL - THERAPIES (Device) $78.50
- VIAGRA (Drug) $75.47
- Lupron (Drug) $70.04
- ELIGARD (Drug) $65.83
- Xtandi (Drug) $63.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Jefferson City
Dr. Katherine Cameron, Md, MD
Urology — Payments: $6,577
Urology $6,577
Dr. Jerry Trulson, M.d, M.D
Urology — Payments: $4,375
Urology $4,375
Eric Vogt, Md, MD
Urology — Payments: $3,183
Urology $3,183
Douglas West, Md, MD
Urology — Payments: $1,536
Urology $1,536
John Koonce, Md, MD
Urology — Payments: $47.73
Urology $47.73